The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?
- PMID: 22382274
- PMCID: PMC3295368
- DOI: 10.1289/ehp.120-a110
The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?
Figures




References
-
- Prasad U, Kurland LK. Arrival of new diseases on Guam: lines of evidence suggesting the post-Spanish origins of ALS and Parkinson’s dementia. J Pac Hist. 1997;32(2):217–228. http://www.jstor.org/pss/25169338.
-
- Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations. Neurology. 1954;4(5):355–378. http://www.ncbi.nlm.nih.gov/pubmed/13185376. - PubMed
-
- Rao SLN, et al. The isolation and characterization of β-N-oxalyl-ʟ-α,β-diaminopropionic acid: a neurotoxin from the seeds of Lathyrus sativus. Biochemistry 33432–436.(1964http://dx.doi.org/10.1021/bi00891a022 - DOI - PubMed
-
- Bell EA. The discovery of BMAA, and examples of biomagnifications and protein incorporation involving other non-protein amino acids. Amyotroph Lateral Scler. 2009;10(suppl 2):21–25. http://www.ncbi.nlm.nih.gov/pubmed/19929727. - PubMed
-
- Vega A, Bell EA. α-Amino-β-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochemistry. 1967;6(5):759–762. http://dx.doi.org/10.1016/S0031-9422(00)86018-5. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical